P. Multhauf

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.

J. Doroshow, L. Leong, S. Akman, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of 4 ′ -deoxydoxorubicin (esorubicin) in advanced or metastatic adenocarcinoma of the stomach

J. Doroshow, L. Leong, S. Akman, 1991, Investigational New Drugs.

High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.

J. Doroshow, L. Leong, B. Carr, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot phase II trial of amphotericin B and CCNU in renal and colorectal carcinomas.

C. Presant, C. Wiseman, P. Kennedy, 1986, European journal of cancer & clinical oncology.

Reversal of cancer chemotherapeutic resistance by amphotericin B--A broad phase I-II pilot study.

C. Presant, G. Metter, P. Multhauf, 1987, European journal of cancer & clinical oncology.

5‐FU versus combination therapy with tubercidin, streptozotocin, and 5‐Fu in the treatment of pancreatic carcinomas: COG protocol 7230

J. Aust, W. Fletcher, T. Grage, 1979, Journal of surgical oncology.

Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial.

A. Bartolucci, J. Gockerman, M. Bertrand, 1985, Cancer treatment reports.

Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors.

G. Ramírez, W. Fletcher, S. Altman, 1978, Cancer treatment reports.

Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer.

J. Doroshow, C. Presant, B. Carr, 1985, Cancer treatment reports.